Format

Send to:

Choose Destination
See comment in PubMed Commons below
Handb Exp Pharmacol. 2009;(190):171-84. doi: 10.1007/978-3-540-79885-9_8.

Aquaporins as potential drug targets for Meniere's disease and its related diseases.

Author information

  • 1Department of Otolaryngology, Head and Neck Surgery, Kochi Medical School, Kohasu, Oko-cho, Kochi, Nankoku, 783-8505, Japan. takedat@kochi-u.ac.jp

Abstract

The homeostasis of water in the inner ear is essential for maintaining function of hearing and equilibrium. Since the discovery of aquaporin water channels, it has become clear that these channels play a crucial role in inner ear fluid homeostasis. Indeed, proteins or mRNAs of AQP1, AQP2, AQP3, AQP4, AQP5, AQP6, AQP7 and AQP9 are expressed in the inner ear. Many of them are expressed mainly in the stria vascularis and the endolymphatic sac, which are the main sites of secretion and/or absorption of endolymph. Vasopressin type2 receptor is also expressed there. Water homeostasis of the inner ear is regulated in part via the arginine vasopressin-AQP2 system in the same fashion as in the kidney, and endolymphatic hydrops, a morphological characteristic of Meniere's disease, is thought to be caused by mal-regulation of this system. Therefore, aquaporins appear to be important for the development of novel drug therapies for Meniere's disease and related disorders.

PMID:
19096777
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk